Semi-Annual Statement Of Income And Retained Earnings

JCR Pharmaceuticals Co.,Ltd. - Filing #7326592

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
7,531,000,000 JPY
7,549,000,000 JPY
5,095,000,000 JPY
4,975,000,000 JPY
Non-operating income
Non-operating income
1,056,000,000 JPY
1,008,000,000 JPY
557,000,000 JPY
541,000,000 JPY
Non-operating expenses
Non-operating expenses
1,324,000,000 JPY
508,000,000 JPY
368,000,000 JPY
99,000,000 JPY
Ordinary profit (loss)
7,264,000,000 JPY
8,048,000,000 JPY
5,284,000,000 JPY
5,418,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
0 JPY
10,000,000 JPY
10,000,000 JPY
Extraordinary losses
Extraordinary losses
20,000,000 JPY
20,000,000 JPY
16,000,000 JPY
16,000,000 JPY
Profit (loss) before income taxes
7,244,000,000 JPY
8,028,000,000 JPY
5,278,000,000 JPY
5,412,000,000 JPY
Income taxes - current
1,788,000,000 JPY
1,743,000,000 JPY
490,000,000 JPY
525,000,000 JPY
Income taxes - deferred
-80,000,000 JPY
-80,000,000 JPY
1,099,000,000 JPY
1,099,000,000 JPY
Profit (loss)
6,364,000,000 JPY
5,536,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,787,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.